Brenig Therapeutics
PrivateLast Round
Series A
Jul 23, 2024
Total Funding Raised
$73M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Brenig Therapeutics is a clinical-stage biotechnology company developing innovative small-molecule therapies for neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brenig Therapeutics Comparables
Compare Brenig Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tenvie Therapeutics | 81% | |
| Neuron23 | 81% | |
| Ventyx Biosciences | 80% |
Brenig Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 23, 2024 | ||||
| Seed | Apr 29, 2021 |
Key People
Founding team and executive leadership
Brenig Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates | Series A |
| OrbiMed | Series A, Seed |
| Torrey Pines Investment LLC | Series A, Seed |
| i2020 Accelerator | Seed |
| BioGeneration Ventures | Series A, Seed |
| Bgvcat | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 130% MoM, reaching 30.1K.
- Jun 22, 2026
Tripled revenue year-over-year for multiple years running.
Recent news
Latest coverage and updates
- signs_new_clientOct 14, 2026
WindBorne Systems signs United States Air Force Academy as a new client under a contract worth up to $49 million to supply weather data from roughly 700 autonomous balloons, with $1.7 million in services ordered so far.
- is_developingOct 12, 2026
WindBorne Systems is expected to further develop AI weather forecasting capabilities
- launchesOct 12, 2026
WindBorne Systems releases WeatherMesh-6 in the United States on Jun 2nd '26, an AI model it claims produces hourly weather predictions and matches the five-day accuracy of conventional government models one day ahead.
- launchesOct 12, 2026
WindBorne Systems released the latest version of its WeatherMesh 6 forecasting model in Summer '26, saying it is more accurate than ECMWF's models.
- signs_new_clientOct 12, 2026
WindBorne Systems signs Air Force as a new client on Oct 12th '26
Brenig Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Brenig Therapeutics's valuation, stock price, and market status.
Is Brenig Therapeutics a public or private company?
Brenig Therapeutics is a private company.
What is the current stock price of Brenig Therapeutics?
Brenig Therapeutics is a private company, so its shares have no public market price. Caplight tracks Brenig Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brenig Therapeutics worth (valuation)?
Valuation information for Brenig Therapeutics is not publicly available.
Can I buy Brenig Therapeutics stock?
Brenig Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brenig Therapeutics's last funding round?
Brenig Therapeutics's most recent funding round was Series A on July 23, 2024.
Who are the main investors in Brenig Therapeutics?
Key investors in Brenig Therapeutics include New Enterprise Associates, OrbiMed, Torrey Pines Investment LLC, BioGeneration Ventures.
Will Brenig Therapeutics IPO soon?
No public IPO plans have been announced for Brenig Therapeutics.
How can I track Brenig Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Brenig Therapeutics's shares on secondary markets.